Philadelphia Trust CO Amgen Inc Transaction History

Philadelphia Trust CO

$1.38 Billion
Q3 2024

A detailed history of Philadelphia Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Philadelphia Trust CO holds 38,526 shares of AMGN stock, worth $10.1 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

38,526

Previous 40,009 3.71%

Holding current value

$10.1 Million

Previous $12.5 Million 0.7%

% of portfolio

0.9%

Previous 0.97%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $458,810 - $500,334	-1,483 Reduced 3.71%	38,526 $12.4 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $113,508 - $137,941	432 Added 1.09%	40,009 $12.5 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $145,458 - $175,586	541 Added 1.39%	39,577 $11.3 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $1 Million - $1.13 Million	3,918 Added 11.16%	39,036 $11.2 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $985,236 - $1.22 Million	-4,506 Reduced 11.37%	35,118 $9.44 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $126,205 - $149,234	589 Added 1.51%	39,624 $8.8 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $3.63 Million - $4.43 Million	16,080 Added 70.05%	39,035 $9.44 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $57,257 - $72,752	250 Added 1.1%	22,955 $6.03 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $29,179 - $32,909	130 Added 0.58%	22,705 $5.12 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $143,040 - $159,178	620 Added 2.82%	22,575 $5.49 Million
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $378,679 - $418,918	-1,727 Reduced 7.29%	21,955 $5.31 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $8.29 Million - $9.48 Million	-41,664 Reduced 63.76%	23,682 $5.33 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $1.05 Million - $1.23 Million	-4,965 Reduced 7.06%	65,346 $13.9 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $488,182 - $541,602	-2,090 Reduced 2.89%	70,311 $17.1 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $100,525 - $117,145	-453 Reduced 0.62%	72,401 $18 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $1.58 Million - $1.89 Million	7,322 Added 11.17%	72,854 $16.8 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $855,299 - $951,162	3,645 Added 5.89%	65,532 $16.7 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.01 Million - $1.24 Million	-5,095 Reduced 7.61%	61,887 $14.6 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $618,704 - $820,571	-3,395 Reduced 4.82%	66,982 $13.6 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $131,500 - $169,024	-695 Reduced 0.98%	70,377 $17 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $1.14 Million - $1.37 Million	-6,568 Reduced 8.46%	71,072 $13.8 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $295,892 - $346,852	1,775 Added 2.34%	77,640 $14.3 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $4.13 Million - $4.66 Million	22,835 Added 43.06%	75,865 $14.4 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $3.87 Million - $4.52 Million	-21,681 Reduced 29.02%	53,030 $10.3 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $6,485 - $7,311	35 Added 0.05%	74,711 $15.5 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $1.08 Million - $1.21 Million	-6,501 Reduced 8.01%	74,676 $13.8 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $527,943 - $616,968	-3,116 Reduced 3.7%	81,177 $13.8 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $1.57 Million - $1.75 Million	-9,284 Reduced 9.92%	84,293 $14.7 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $15.7 Million - $17.9 Million	93,577	93,577 $17.4 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Account

Philadelphia Trust CO Amgen Inc Transaction History